摘要 |
<p>An anti-retroviral drug containing an active ingredient comprising at least one member selected from the group consisting of ''syosaikoto'', baicalein, baicalin, quercetin, hesperetin, and alizarin represented by formula (I) (wherein R1, R2 and R3, which may be the same or different, each represents a hydrogen atom or a hydroxy group, and R4 represents a hydrogen atom, a sulfo group or a dicarboxymethylaminomethyl group), derivatives thereof and pharmacologically acceptable salts thereof. This drug is effective in treating human diseases induced by retrovirus.</p> |